Sleep-related breathing disorder (central sleep apnoea) improved coincidentally by medical therapy with fumarates (dimethyl fumarate)

Abdulmajeed M Albadi, Mana M Alshahrani, Riyad O Allehebi

Article Type

Case Report

Published

In this article, the authors describe a case study of a 31-year-old woman known to have multiple sclerosis and concomitant severe central sleep apnoea (CSA). She received the medication dimethyl fumarate for the treatment of multiple sclerosis, and her CSA significantly improved to mild CSA after the treatment.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.